5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents

Details for Australian Patent Application No. 2004295047 (hide)

Owner Actelion Pharmaceuticals Ltd

Inventors Scherz, Michael; Mueller, Claus; Binkert, Christoph; Nayler, Oliver; Bolli, Martin; Mathys, Boris

Agent A J Park

Pub. Number AU-B-2004295047

PCT Pub. Number WO2005/054215

Priority PCT/EP03/13072 21.11.03 EP

Filing date 16 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 10 March 2011

International Classifications

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/054215 Priority application(s): WO2005/054215

7 December 2006 Amendment Made

  The nature of the amendment is: Add co-inventor Nayler, Oliver

10 March 2011 Application Accepted

  Published as AU-B-2004295047

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295048-3-aminopyrrolidone derivatives

2004295043-Cyclopentyl derivatives